Active Filter(s):
Details:
The Hebrew University Portfolio Company addresses modern medicine’s number one problem: extending lifespan without disease and has the potential to improve quality of life for the world’s rapidly growing aging population.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: Hebrew University
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 23, 2022